Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Abiraterone ACetate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02159690
What this trial is testing

A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy

Who this might be right for
Prostate CancerLocalized Prostate Cancer
Kenneth Pienta, MD
Early research (Phase 1)Study completedNCT01798628
What this trial is testing

Determine the Effect of Food on the Pharmacokinetics of Abiraterone Acetate in Healthy Male Patients

Who this might be right for
Healthy Volunteers
Cougar Biotechnology, Inc. 36
Testing effectiveness (Phase 2)Looking for participantsNCT06689163
What this trial is testing

The Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone

Who this might be right for
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 66
Early research (Phase 1)Study completedNCT02740985
What this trial is testing

Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid MalignanciesNon-Small Cell Lung Cancer (NSCLC)Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC)+1 more
AstraZeneca 313
Large-scale testing (Phase 3)Looking for participantsNCT07723248
What this trial is testing

Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
ORIC Pharmaceuticals 600
Not applicableWithdrawnNCT02608359
What this trial is testing

A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Johnson & Johnson Private Limited
Testing effectiveness (Phase 2)Study completedNCT03002220
What this trial is testing

Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Status

Who this might be right for
Prostate Cancer
MedSIR 52
Large-scale testing (Phase 3)Looking for participantsNCT06136624
What this trial is testing

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

Who this might be right for
Prostate Cancer Metastatic
Merck Sharp & Dohme LLC 1,310
Testing effectiveness (Phase 2)Active Not RecruitingNCT03419234
What this trial is testing

Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma in the Soft Tissue+2 more
ECOG-ACRIN Cancer Research Group 223
Not applicableStudy completedNCT04268628
What this trial is testing

Pharmacodynamic and Genetic Parameters of Abira-DES Study Participants (NCT02217566) - Participants With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Following Unresponsive Treatment With Diethylstilbestrol

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Janssen-Cilag Farmaceutica Ltda. 42
Not applicableActive Not RecruitingNCT07721532
What this trial is testing

Observing the Real-world Non-interventional Study of Abiraterone Acetate Tablets (II) in Treating Chinese Patients With Metastatic Prostate Cancer

Who this might be right for
Diagnosed With Metastatic Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 3,000
Large-scale testing (Phase 3)Active Not RecruitingNCT03748641
What this trial is testing

Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

Who this might be right for
Castration-Resistant Prostatic Cancer
Janssen Research & Development, LLC 765
Testing effectiveness (Phase 2)Study completedNCT01867710
What this trial is testing

Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy

Who this might be right for
Prostate Cancer
Janssen Pharmaceutica N.V., Belgium 164
Early research (Phase 1)Study completedNCT00910754
What this trial is testing

A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 33
Testing effectiveness (Phase 2)Looking for participantsNCT06844383
What this trial is testing

Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

Who this might be right for
Prostate Cancer (Adenocarcinoma)mCRPC (Metastatic Castration-resistant Prostate Cancer)
Prostate Cancer Clinical Trials Consortium 126
Early research (Phase 1)Active Not RecruitingNCT06421935
What this trial is testing

M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 60
Large-scale testing (Phase 3)Active Not RecruitingNCT03706365
What this trial is testing

Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

Who this might be right for
Prostate Cancer
Eli Lilly and Company 393
Early research (Phase 1)Study completedNCT01362764
What this trial is testing

Assess the Relative Bioavailability of Two Abiraterone Acetate Suspension Formulations Compared to the Abiraterone Acetate Tablet Formulation in Healthy Adult Volunteers

Who this might be right for
Healthy Volunteers
Cougar Biotechnology, Inc. 30
Not applicableUnknownNCT03414437
What this trial is testing

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

Who this might be right for
Prostate Cancer Metastatic
Carolina Research Professionals, LLC 31
Testing effectiveness (Phase 2)Study completedNCT00924469
What this trial is testing

Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 58
Next Page